NBTY's Julian Graves acquisition clears
This article was originally published in The Tan Sheet
U.K. regulators July 22 clear supplement firm NBTY's acquisition of 350-store U.K. confectionery chain Julian Graves. The OK followed provisional findings by the Competition Commission, the Ronkonkoma, N.Y.-based firm said. The firm purchased Julian Graves in September for $25 million, but the commission raised concerns the acquisition could obstruct competition in the market for seeds, nuts and dried fruit (1"The Tan Sheet" July 20, 2009). NBTY said it expects the commission to make a final decision before Sept. 4
You may also be interested in...
NBTY hopes to remain a supplement industry giant in part by continuing to acquire other businesses, a strategy with an improving outlook as opportunities emerge during the global economic slump
A list of EU biosimilar filings, CHMP opinions and EU marketing authorizations, including details of the biosimilar company, the brand name/INN, indication(s), the reference product/company, and the date and type of event.
American Injectables gets a new CEO, while Hemostemix names a new chief medical officer.